Comgest Growth Europe USD Z AccRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 30/09/2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | - | - | -20,3 | 23,7 | 7,7 | |
+/-Cat | - | - | 0,2 | 7,6 | -0,6 | |
+/-Idx | - | - | - | 7,5 | -4,4 | |
Categorie: Aandelen Europa Large-Cap Groei | ||||||
Benchmark: Morningstar DM Europe Grt T... |
Kerngegevens | ||
Koers 30/10/2024 | USD 11,81 | |
Rendement 1 Dag | -1,93% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Groei | |
ISIN | IE00BMBWVM76 | |
Grootte Fonds (Mil) 29/10/2024 | EUR 5988,16 | |
Grootte Fondsklasse (Mil) 29/10/2024 | USD 0,98 | |
Aankoopkosten (Max) | 2,00% | |
Lopende Kosten Factor 04/06/2024 | 1,11% | |
Gesloten voor nieuwe beleggers | nee |
Morningstar Research |
Analyst Report | 11/07/2024 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Klik hier voor het analistenrapport |
Pijlers Morningstar | |
---|---|
Team | 25 |
Fondshuis | 24 |
Proces | 25 |
Rendement | |
Kosten |
Beleggingsdoelstelling: Comgest Growth Europe USD Z Acc |
The investment objective of the Comgest Growth Europe fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies based or operating in Europe. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Franz Weis 01/11/2009 | ||
Eva Fornadi 30/08/2024 | ||
Click here to see others | ||
Oprichtingsdatum 06/04/2021 |
Advertentie |
Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI Europe NR EUR | Morningstar DM Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Comgest Growth Europe USD Z Acc | 31/07/2024 |
|
|
Top 5 posities | Sector | % |
Novo Nordisk A/S Class B | Gezondheidszorg | 8,58 |
ASML Holding NV | Technologie | 7,85 |
Essilorluxottica | Gezondheidszorg | 5,35 |
Accenture PLC Class A | Technologie | 4,29 |
Alcon Inc | Gezondheidszorg | 4,16 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
Comgest Growth Europe USD Z Acc |